Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes.

Autor: Dzeshka MS; Department of Internal Medicine I, Grodno State Medical University, Grodno, Belarus mikhail.dzeshka@grsmu.by., Shantsila A; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK., Shantsila E; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.; Department of Primary Care and Mental Health, University of Liverpool, Liverpool, UK., Lip GYH; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.; Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Publikováno v: Heart (British Cardiac Society) [Heart] 2023 Dec 20; Vol. 110 (2), pp. 75-76. Date of Electronic Publication: 2023 Dec 20.

Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?

Autor: Dzeshka MS; Grodno State Medical University, Grodno, Belarus. Electronic address: mikhail.dzeshka@grsmu.by., Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Publikováno v: Trends in cardiovascular medicine [Trends Cardiovasc Med] 2020 Feb; Vol. 30 (2), pp. 91-92. Date of Electronic Publication: 2019 Apr 27.

Atrial Fibrillation and Hypertension.

Autor: Dzeshka MS; From the Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (M.S.D., A.S., E.S., G.Y.H.L.); Grodno State Medical University, Belarus (M.S.D.); and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L.)., Shantsila A; From the Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (M.S.D., A.S., E.S., G.Y.H.L.); Grodno State Medical University, Belarus (M.S.D.); and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L.)., Shantsila E; From the Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (M.S.D., A.S., E.S., G.Y.H.L.); Grodno State Medical University, Belarus (M.S.D.); and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L.)., Lip GYH; From the Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (M.S.D., A.S., E.S., G.Y.H.L.); Grodno State Medical University, Belarus (M.S.D.); and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L.). g.y.h.lip@bham.ac.uk.

Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2017 Nov; Vol. 70 (5), pp. 854-861. Date of Electronic Publication: 2017 Sep 11.

Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.

Autor: Dzeshka MS; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, West Midlands B18 7QH, UK; Department of Internal Medicine I, Grodno State Medical University, Gorkogo 80, Grodno 230009, Belarus., Brown RA; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, West Midlands B18 7QH, UK., Capodanno D; Cardio-Thoracic-Vascular Department, Ferrarotto Hospital, University of Catania, Via Salvatore Citelli 6, CT 95124, Italy., Lip GY; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, West Midlands B18 7QH, UK; Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg Hospital Science and Innovation Center, Søndre Skovvej 15, Aalborg 9100, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.

Publikováno v: Interventional cardiology clinics [Interv Cardiol Clin] 2017 Jan; Vol. 6 (1), pp. 91-117.

Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.

Autor: Dzeshka MS; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK; Grodno State Medical University, Grodno, Belarus., Lip GY; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK. Electronic address: g.y.h.lip@bham.ac.uk.

Publikováno v: Heart failure clinics [Heart Fail Clin] 2016 Apr; Vol. 12 (2), pp. 257-71.